Home > Insider Trading > Filing (0000947871-10-000033)

Filing Details

Accession Number:: 0000947871-10-000033
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-01-08 12:00:00
Reporting Period:: 2010-01-04

Filing Date:: 2010-01-08
Accepted Time:: 2010-01-08 11:28:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1053369	Elite Pharmaceuticals Inc	ELTP	Pharmaceutical Preparations (2834)	223542636

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1211019	Trellus Partners Ii Lp	C/O Trellus Management Company, Llc 350 Madison Avenue New York NY 10017	No	No	Yes	No
1307877	Trellus Management Company, Llc	350 Madison Avenue - 9Th Fl New York NY 10017	No	No	Yes	No
1458673	Ltd Fund Offshore Trellus	350 Madison Avenue, 9Th Floor New York NY 10017	No	No	Yes	No
1459107	Adam Usdan	C/O Trellus Management Company, Llc 350 Madison Avenue, 9Th Floor New York NY 10017	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-01-04	173,271	$0.11	23,816,006	No	4	S	Indirect	See footnote
Common Stock	Disposition	2010-01-06	138,192	$0.11	23,677,814	No	4	S	Indirect	See footnote
Common Stock	Disposition	2010-01-07	158,250	$0.11	23,519,564	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

On January 4, 2010, Trellus Partners, L.P., a Delaware limited partnership ("TPLP") sold 115,100 shares of Common Stock and Trellus Offshore Fund Limited, a Cayman Islands limited liability company ("TOF") sold 58,171 shares of Common Stock.
On January 4, 2010, following the reported transaction, TPLP owned 12,715,821 shares of Common Stock and held warrants to acquire 3,291,426 shares of Common Stock and TOF owned 6,230,019 shares of Common Stock and held warrants to acquire 1,377,758 shares of Common Stock. Trellus Management Company, LLC ("Trellus") and Mr. Usdan each beneficially owned the Common Stock and warrants owned by TPLP and TOF and in addition held indirect beneficial ownership of an additional 167,103 shares of Common Stock and additional warrants to acquire 33,789 shares of Common Stock.
Trellus is the investment adviser to TPLP and TOF. Adam Usdan is the controlling principal and chief investment officer of Trellus. By reason of their investment discretion, Trellus and Mr. Usdan are reported herein as indirect beneficial owners of the securities held, acquired, and sold by TPLP and TOF (as described in footnotes (1), (2), (5), (6), (7) and (8)).
Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
On January 6, 2010, TPLP sold 91,900 shares of Common Stock and TOF sold 46,292 shares of Common Stock.
On January 6, 2010, following the reported transaction, TPLP owned 12,623,921 shares of Common Stock and held warrants to acquire 3,291,426 shares of Common Stock and TOF owned 6,183,727 shares of Common Stock and held warrants to acquire 1,377,758 shares of Common Stock. Trellus and Mr. Usdan each beneficially owned the Common Stock and warrants owned by TPLP and TOF and in addition held indirect beneficial ownership of an additional 167,103 shares of Common Stock and additional warrants to acquire 33,879 shares of Common Stock.
On January 7, 2010, TPLP sold 105,250 shares of Common Stock and TOF sold 53,000 shares of Common Stock.
On January 7, 2010, following the reported transaction, TPLP owned 12,518,671 shares of Common Stock and held warrants to acquire 3,291,426 shares of Common Stock and TOF owned 6,130,727 shares of Common Stock and held warrants to acquire 1,377,758 shares of Common Stock. Trellus and Mr. Usdan each beneficially owned the Common Stock and warrants owned by TPLP and TOF and in addition held indirect beneficial ownership of an additional 167,103 shares of Common Stock and additional warrants to acquire 33,879 shares of Common Stock.